The carbapenem resistance determinant bla NDM-1 has been found in various Gram-negative bacteria and upon different plasmid replicon types (Inc). Here, we present four patients within two hospitals in Pakistan harboring between two and four NDM-1-producing Gram-negative bacilli of different species coresident in their stool samples. We characterize the bla NDM-1 genetic contexts of these 11 NDM-1-producing Gram-negative bacilli in addition to other antimicrobial resistance mechanisms, plasmid replicon profiles, and sequence types (STs) in order to understand the underlying acquisition mechanisms of carbapenem resistance within these bacteria. Two common plasmid types (IncN2 and IncA/C) were identified to carry bla NDM-1 among the six different bacterial species isolated from the four patients. Two of these strains were novel Citrobacter freundii ST 20 and ST 21. The same IncN2-type bla NDM-1 genetic context was found in all four patients and within four different species. The IncA/C-type bla NDM-1 genetic context was found in two different species and in two of the four patients. Combining genetic context characterization with other molecular epidemiology methods, we were able to establish the molecular epidemiological links between genetically unrelated bacterial species by linking their acquisition of an IncN2 or IncA/C plasmid carrying bla NDM-1 for carbapenem resistance. By combining plasmid characterization and in-depth genetic context assessment, this analysis highlights the importance of plasmids in antimicrobial resistance. It also provides a novel approach for investigating the underlying mechanisms of bla NDM-1 -related spread between bacterial species and genera via plasmids.
I
nfectious pathogens have the ability to be transmitted from one person to another. Antimicrobial resistance in certain instances has been observed to follow this paradigm of transmission; specifically, bacterial species have been described as transmitting antimicrobial resistance determinants. A well-known example of a successful international clone is the Escherichia coli sequence type (ST) 131 transmitting bla CTX-M-15 (1, 2) . However, numerous reports in the last few years provide evidence that plasmids are a major factor in the transmission of antimicrobial resistance (3, 4) .
Since the first report (5) , bla NDM has been reported to be harbored by a diverse range of bacterial species, among which the most frequent are within the Acinetobacter genus and Enterobacteriaceae family (6, 7) . Furthermore, bla NDM has also been identified to reside upon different plasmid replicon types (Inc) among the Enterobacteriaceae family, including IncA/C (8), IncF types (9) , IncL/M (10), IncN (11) , IncX (12) , and IncH (13) . In addition, the genetic structure or context in which bla NDM resides varies between different plasmid types and even within the same plasmid type (14) . The bla NDM-1 genetic contexts observed with Enterobacteriaceae plasmids frequently involve various mechanisms of gene acquisition, including different ISCR elements (15) , class one integrons (16) , flanking insertion (IS) elements (15) , and singleton IS elements present in close proximity (8, 10 ). In contrast, bla NDM genetic contexts within Acinetobacter spp. have been reported with less variation since bla NDM can be commonly found within the 10,099-bp transposon known as Tn125, composed of two flanking ISAba125 sequences (7, (17) (18) (19) .
The Indian subcontinent is recognized as a major reservoir for bla NDM acquisition and has been suggested as the geographical origin of bla NDM (6, 20) . In a previous study from our group, 66 NDM-1-producing Gram-negative isolates from stool samples of patients in two Pakistani hospitals were reported (20) . Among patients harboring these isolates, four patients were found to carry multiple NDM-1 producers of different species. Sartor and colleagues also determined that the species within each patient were characterized by different plasmid replicon type profiles (20) . This warranted further investigation in order to elucidate the underlying nature of bla NDM-1 acquisition by different species when the bacterial hosts have different plasmid replicon profiles. The aim of this study was to further characterize the different NDM-producing bacterial species coexisting in multiple patients through whole-genome sequencing, noting their resistance mechanisms and sequence types (STs) with a further focus on characterizing the bla NDM-1 genetic contexts.
(Part of this work was presented as a poster at the 25th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark, 25 to 28 April 2015).
MATERIALS AND METHODS

Bacterial isolates.
Eleven clinical isolates were acquired in 2010 from stool samples from four different patients in two hospitals in Rawalpindi, Pakistan (21) . In the study conducted by Perry and colleagues (21) , one patient carried four species, three patients had three species, and five patients had two species of NDM-1 producers (data not shown). Isolates were selected based on the number of isolates present in the patients and the diversity of their plasmid type profiles, which was determined by PCR-based replicon typing (PBRT) of Enterobacteriaceae isolates as previously described (20, 22) . The strains identified from each patient are as follows ( Plasmid transfer experiments through conjugation. Plasmids carrying bla NDM-1 from clinical strains were transferred by conjugation to confirm their transferability and plasmid replicon type. For conjugation experiments, the 11 clinical isolates (donor strains) were verified to be susceptible to sodium azide via agar dilution. Donor strains and sodium azide-resistant E. coli J53 recipients were grown in LB broth at 200 rpm to logarithmic phase (23) . The conjugation mixture consisted of donor and recipient strains in a 1:1 ratio that were plated onto MacConkey agar and then incubated at 37°C overnight (24) . The conjugation mixture of approximately 20 l of confluent growth on the plate was then harvested into 1 ml of saline and serially diluted in saline to 10
Ϫ8 . This serial dilution method was performed to obtain single colonies of both donors and transconjugants between the serial dilutions of 10 Ϫ4 and 10 Ϫ6 . One hundred microliters of each dilution was then inoculated onto MacConkey agar supplemented with meropenem (0.1 g/ml) and sodium azide (100 g/ml) or with sodium azide only (100 g/ml) and onto a control plate without additives; plates were incubated at 37°C for 24 h. Successful transconjugants were confirmed phenotypically and through PCR for bla NDM-1 . PBRT was performed on transconjugants to identify the plasmid replicon type carrying bla NDM-1 (22) .
Sequencing and bioinformatics. Paired-end libraries of whole genomic DNA of all 11 clinical isolates were prepared and sequenced by the Illumina MiSeq platform (Illumina, San Diego, CA, USA). All sequences were de novo assembled using the CLC Genomic Workbench, version 7.5 (CLC Bio, Aarhus, Denmark). pNDM-BJ01 (GenBank accession number JQ001791) (17) was manually annotated and used as a reference for Tn125 structure annotation. Sequences from the GenBank database and IS Finder (https://www-is.biotoul.fr/) were used to identify and characterize genes flanking the Tn125 region. The CLC Genomic Workbench was used for a BLAST search (http://blast.ncbi.nlm.nih.gov /Blast.cgi) and to analyze and manually annotate the genetic context of bla NDM-1 according to the aforementioned reference sequences. Contigs containing bla NDM-1 were named as follows: patient 1, pPN2-ECL-NDM-1 (E. cloacae Pn2), PN3-AB-NDM-1 (A. baumannii Pn3), pPN4-KP-NDM-1 (K. pneumoniae Pn4), and PN5-CF-NDM-1 (C. freundii Pn5); patient 2, pPN13-PCF-NDM-1 (P. faecalis Pn13) and pPN14-EC-NDM-1 (E. coli Pn14); patient 3, pPN27-PCF-NDM-1 (P. faecalis Pn27) and PN28-EC-NDM-1 (E. coli Pn28); patient 4, pPN66-EC-NDM-1 (E. coli Pn66), pPN67-CF-NDM-1 (C. freundii Pn67), and pPN68-ECL-NDM-1 (E. cloacae Pn68).
Contigs of each clinical strain were submitted to the ResFinder, version 2.1 (25) (https://cge.cbs.dtu.dk/services/ResFinder/), and PlasmidFinder, version 1.1 (26) , databases (available at the Center of Genomic Epidemiology website [http://www.genomicepidemiology.org]) to characterize their resistance mechanism genes and plasmid Inc types.
Sequence typing via an MLST scheme. Each clinical isolate was submitted to the MLST, version 1.7, database (27) (https://cge.cbs.dtu.dk /services/MLST/) for sequence typing via respective multilocus sequence typing (MLST) schemes, except for P. faecalis strains Pn13 and Pn27 as no MLST schemes were available (28) . Both C. freundii strain Pn5 and strain Pn65 were identified as novel sequence types and subsequently submitted to the C. freundii MLST website (http://pubmlst.org/cfreundii/) (29) for assignment of new sequence types.
Nucleotide sequence accession numbers. Each nucleotide sequence was deposited in the GenBank database under the following accession number: pPN2-ECL-NDM-1, KP770024; PN3-AB-NDM-1, KP770025; pPN4-KP-NDM-1, KP770033; PN5-CF-NDM-1, KP770032; pPN13-PCF-NDM-1, KP770031; pPN14-EC-NDM-1, KP770030; pPN27-PCF-NDM-1, KP770029; PN28-EC-NDM-1, KP770023; pPN66-EC-NDM-1, KP770028; pPN67-CF-NDM-1, KP770027; and pPN68-ECL-NDM-1, KP770026.
RESULTS AND DISCUSSION
The molecular and in silico analysis results of each NDM-1-producing strain are summarized in Table 1 . These results also include for each strain the clinically significant antimicrobial resistance determinants found within each strain, ST type, and replicon type (Inc) of the plasmid carrying bla NDM-1 (determined via PBRT of successful transconjugants). In silico analysis of each contig with bla NDM-1 initially identified a truncated Tn125 structure harboring bla NDM-1 (⌬Tn125). The sizes of ⌬Tn125 structures were variable (Fig. 1) . Different genes and IS elements were identified flanking the ⌬Tn125 structures (Fig. 1 ). The combination of the different ⌬Tn125 structure sizes and flanking contexts identified four distinct bla NDM-1 genetic contexts.
The most common bla NDM-1 genetic context, 5=-aacA1 ⌬bla OXA-10 ⌬Tn125-3= (identified in 5 of 11 strains and in all four patients), contained a 2,341-bp ⌬Tn125 structure with aacA1 conferring aminoglycoside resistance and a truncated narrow-spectrum ␤-lactamase, bla OXA-10 , upstream and was determined to be on IncN2-type plasmids (expect in Pn28 and Pn67). This bla NDM-1 genetic context was found within three different bacterial species, K. pneumoniae Pn4 (pPN4-KP-NDM-1), P. faecalis Pn13 and Pn27 (pPN13-PCF-NDM-1 and pPN27-PCF-NDM-1, respectively), E. coli Pn14 and Pn28 (pPN14-EC-NDM-1 and PN28-EC-NDM-1, respectively), and C. freundii Pn67 (pPN67-CF-NDM-1), and is similar to an E. coli isolate from Japan (direct submission under GenBank accession number AB769140) and to two IncN3 plasmids, pLK75 (GenBank accession number KJ440076) of E. coli and pLK78 (GenBank accession number KJ440075) of K. pneumoniae isolated from Taiwan (11) . Transmission of bla NDM-1 may have occurred via conjugation of an IncN2 plasmid with this genetic context, as suggested by our successful conjugation experiments involving strains carrying IncN2 plasmids. These conjugation events would subsequently result in the different bacterial
FIG 1
Schematic representation of all bla NDM genetic contexts described within this study and the reference sequence pNDM-BJ01 (GenBank accession number JQ001791). bla NDM genetic contexts and their GenBank accession numbers are as follows: Pn2, pPN2-ECL-NDM-1 (KP770024); Pn3, PN3-AB-NDM-1 (KP770025); Pn4, pPN4-KP-NDM-1 (KP770033); Pn5, PN5-CF-NDM-1 (KP770032); Pn13, pPN13-PCF-NDM-1 (KP770031); Pn14, pPN14-EC-NDM-1 (KP770030); Pn27, pPN27-PCF-NDM-1 (KP770029); Pn28, PN28-EC-NDM-1 (KP770023); Pn66, pPN66-EC-NDM-1 (KP770028); Pn67, pPN67-CF-NDM-1 (KP770027); and Pn68, pPN68-ECL-NDM-1 (KP770026). ⌬, truncated gene. Insertion sequence (IS) elements are represented as block arrows.
species producing NDM-1 within three of the four patients. The IncN2 bla NDM-1 genetic context was also found in C. freundii Pn67 in the fourth patient; however, it was identified on an IncFII Y -type plasmid. This genetic context was also identified in E. coli Pn28 and believed to be located on the chromosome or on a nonconjugative plasmid as conjugation experiments were unsuccessful after multiple attempts. The bla NDM-1 genetic contexts in Pn28 and Pn67 are highly similar to those of the IncN2 plasmids of our study as well as to those in the literature; however, they were not located on IncN2 plasmids. It may be speculated the "IncN-like" bla NDM-1 genetic contexts of Pn28 and Pn67 may have diverged from the IncN2 plasmids of our study through such events as homologous recombination (30) . Alternatively, Pn28 and Pn67 could have been the source from which the IncN2 plasmids acquired the bla NDM-1 genetic context prior to horizontal gene transfer among the different species. Further investigation, including full plasmid construction, will be required to clarify the nature of these two isolates and the potential for bla NDM-1 cassette transfer between the plasmid backbones IncN2 and IncFII Y .
Another bla NDM-1 genetic context observed, found in 3 of the 11 isolates, involved a longer 6,332-bp ⌬Tn125 structure. In contrast to the aforementioned IncN2 ⌬Tn125 structure, this longer ⌬Tn125 structure was flanked by an ISKpn14 element and truncated ISEcp1 upstream and by a truncated type IV secretion protein, rhs, downstream (Fig. 1) . This IncA/C bla NDM-1 genetic context was determined to be on IncA/C-type plasmids and was found in two patients, patient 1, carrying E. cloacae strain Pn2 (pPN2-ECL-NDM-1), and patient 4, carrying E. coli strain Pn66 (pPN66-EC-NDM-1) and E. cloacae strain Pn68 (pPN68-ECL-NDM-1). Similar to the aforementioned IncN2 bla NDM-1 genetic contexts, the IncA/C bla NDM-1 genetic context was also observed within two different species within the same patient (patient 4). Further, it is very similar to the most frequently reported IncA/C bla NDM-1 genetic context of the Enterobacteriaceae family (8, 14, 31) . The combination of IncA/C bla NDM-1 genetic context identification (Fig.  1) , the previously reported clonal spread of E. cloacae and E. coli within these hospitals, and the identification of IncA/C plasmids as the most prevalent plasmid types (20) might suggest the contribution of this specific IncA/C plasmid to the carriage and transmission of carbapenem resistance among Enterobacteriaceae within this clinical setting.
Out of the 11 isolates, two unique genetic contexts for bla NDM-1 were found in PN3-AB-NDM-1 (A. baumannii Pn3) and PN5-CF-NDM-1 (C. freundii Pn5) in patient 1. PN3-AB-NDM-1 carried a context composed of the longest Tn125 structure (7,962 bp), which is very similar to the Tn125 lengths frequently described within the Acinetobacter genus; i.e., it was composed of a full Tn125 structure extending from the left-hand ISAba125 element to the right-hand ISAba125 (7, 18, 32, 33) . PN5-CF-NDM-1 contained a 7,288-bp ⌬Tn125 structure flanked by two IS3000 sequences (truncated left-hand ISAba125 to truncated ISCR27) with plasmid backbone elements in close proximity, such as traA. This context has not been previously reported. Both bla NDM-1 genetic contexts, PN3-AB-NDM-1 and PN5-CF-NDM-1, may potentially be located on a nonconjugative plasmid or on the chromosome, as suggested by unsuccessful transfers in conjugation experiments. Of note, both PN3-AB-NDM-1 and PN5-CF-NDM-1 were found in patient 1, who carried four different NDM-1-producing species, i.e., E. cloacae, A. baumannii, K. pneumoniae, and C. freundii, each with a different bla NDM-1 genetic context (Fig. 1) .
The characterized bla NDM-1 genetic contexts of 11 clinical isolates retrospectively may suggest interspecies transmission of antimicrobial resistance at an in vivo level via plasmids. This has been previously described with bla KPC (34) . Initial characterization of our isolates identified different plasmid replicon profiles with multiple species within the same patient. Genetic characterization in combination with other molecular typing methods has described, clarified, and provided an insight into the spread and acquisition of bla NDM-1 . Apart from the nonconjugative bla NDM-1 found in Pn3, Pn5, and Pn28 and the single IncFII Y plasmid in Pn67, the remaining strains have become carbapenem resistant by acquiring IncN2-and IncA/C-type plasmids with the specific aforementioned bla NDM-1 genetic contexts.
The prevalence of highly similar bla NDM-1 genetic contexts within different species and among different patients highlights the possible role plasmids are able to provide in interspecies transmission of carbapenem resistance. We suggest that genetic characterization of plasmids with respect to bla NDM-1 could be considered a tool similar to the multilocus sequencing typing (MLST) approach, which utilizes the typing of conserved regions within the genome for comparison, to investigate the clonal epidemiology of antibiotic-resistant bacteria (1, 35, 36) . By considering genetic context characterization in combination with standard molecular methods (bacterial species identification, resistance mechanism profiling, and clonality via MLST) during epidemiological studies, sophisticated epidemiological links between patients and genetically unrelated bacterial species can be clarified in the case of bla NDM-1 and potentially other plasmid-mediated antimicrobial resistance determinants that have genetic context variation, such as bla CTX-M-type (37, 38) or bla CMY-type (39) . Such investigation will assist in clarifying whether within a specific geographical region and facility antimicrobial resistance acquisition by species has occurred via a particular plasmid with a specific genetic context.
Here, we have characterized the genetic nature in which bla NDM-1 resides in different NDM-1-producing bacterial species coexisting in multiple patients and identified IncA/C and IncN2 plasmids as the platform providing carbapenem resistance to otherwise diverse and unrelated species of Enterobacteriaceae within the clinical setting of two hospitals in Pakistan. The combination of in-depth genetic plasmid characterization and epidemiological molecular investigation methods presented here not only highlights the ability of plasmids to transmit and provide antimicrobial resistance determinants to various bacterial species and genera but also provides a novel approach for investigating the underlying mechanisms of bla NDM-1 -related spread associated with hospitalized patients.
